Patents Assigned to ALIANZA ESPAÑOLA DE FAMILIAS DE VON HIPPEL-LINDAU-VHL
  • Compounds for treating von Hippel-Lindau disease
    Patent number: 11730707
    Abstract: The invention relates to the use of a selective ?2 adrenergic receptor antagonist for treating and preventing a tumor in a patient with von Hippel-Lindau syndrome. In particular, the invention relates to the use of an alkanolamine derivative or a pharmaceutically acceptable acid-addition salt thereof for treating and preventing a hemangioblastoma in VHL syndrome patients.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: August 22, 2023
    Assignees: ALIANZA ESPAÑOLA DE FAMILIAS DE VON HIPPEL-LINDAU-VHL, CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS
    Inventors: Luisa María Botella Cubells, Virginia Albiñana Díaz, Karina Villar Gomez-De Las Heras